Newly discovered biomarkers could be key to predicting severity of brain tumor recurrence

(Henry Ford Health System) Researchers have identified predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study, led by Henry Ford Health System, was published today in Cell Reports. In an analysis of 200 tumor samples, the authors identified a set of epigenetic biomarkers that can predict, at a patient's initial diagnosis, which tumors are likely to recur with a more aggressive tumor type.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news